Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - T2 Biosystems, Inc. | ttoo-ex322_9.htm |
| EX-32.1 - EX-32.1 - T2 Biosystems, Inc. | ttoo-ex321_14.htm |
| EX-31.2 - EX-31.2 - T2 Biosystems, Inc. | ttoo-ex312_13.htm |
| EX-31.1 - EX-31.1 - T2 Biosystems, Inc. | ttoo-ex311_6.htm |
| EX-21.1 - EX-21.1 - T2 Biosystems, Inc. | ttoo-ex211_11.htm |
| EX-10.65 - EX-10.65 - T2 Biosystems, Inc. | ttoo-ex1065_724.htm |
| EX-10.64 - EX-10.64 - T2 Biosystems, Inc. | ttoo-ex1064_723.htm |
| EX-10.63 - EX-10.63 - T2 Biosystems, Inc. | ttoo-ex1063_722.htm |
| EX-10.3 - EX-10.3 - T2 Biosystems, Inc. | ttoo-ex103_858.htm |
| EX-4.4 - EX-4.4 - T2 Biosystems, Inc. | ttoo-ex44_639.htm |
| 10-K - 10-K - T2 Biosystems, Inc. | ttoo-10k_20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
T2 Biosystems, Inc.
Lexington, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-206707, No. 333-216833, No. 333-225275, and No. 333-227847) and Form S-8 (No. 333-197946, No. 333-227850, and No. 333-238727) of T2 Biosystems, Inc. of our report dated March 31, 2021, relating to the consolidated financial statements, which appear in this Annual Report on Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/BDO USA, LLP
Boston, Massachusetts
March 31, 2021